Back to news

August 18, 2020 | Local, Aerospace

Icarus Aerospace reveals clean sheet light attack and ISR designs

by Gareth Jennings

Icarus Aerospace has revealed a clean sheet design for an optionally-piloted armed overwatch and light strike aircraft that can also be adapted into mid/high-altitude long-endurance intelligence, surveillance, and reconnaissance (ISR) platform.

The Canadian company revealed designs for the Tactical Air Vehicle (TAV) light strike and derived Branta ISR platform in August, with the former described as “a force multiplier for the world's security and armed forces”, and the latter as “the next logical step in [the] evolution of modern drones and reconnaissance aircraft”.

In terms of the twin-turboprop TAV (named Wasp in its full-up military guise), Icarus boasts a mission-specialised swing-role platform that will be capable of operating in austere locations with 90% of the mission capability rate of a modern combat jet with just 15% of the costs.

Limited details revealed to date show the platform has up to three times the electrical-power generation capabilities as its contemporaries, is capable of aerial refuelling, has the highest payload and fastest cruise speed in its class, an optional 360° active electronically scanned-array (AESA) radar provided by Leonardo, as well as a network centric capability that enables a swarming capability.

“[The TAV is] a perfect and affordable plug-and-play solution, replacing and outperforming ageing and near obsolete fleets of more expensive helicopters, aircraft, and drones,” the company said.

https://www.janes.com/defence-news/news-detail/icarus-aerospace-reveals-clean-sheet-light-attack-and-isr-designs

On the same subject

  • B-Temia gagne en force aux États-Unis

    September 15, 2020 | Local, Land

    B-Temia gagne en force aux États-Unis

    La firme a obtenu le feu vert de la Food and Drug Administration pour commercialiser son exosquelette L'entreprise B-Temia décroche les autorisations nécessaires pour commercialiser son exosquelette aux États-Unis et n'écarte pas la possibilité d'y ouvrir une usine de production. Par ailleurs, la direction a des discussions pour un possible contrat avec l'armée suisse. Hier, la Food and Drug Administration (FDA) a donné le feu vert à la compagnie de Québec pour vendre son système dermosquelette d'assistance à la marche motorisé Keeogo aux personnes ayant des limitations physiques en raison de problèmes de santé. « Les États-Unis représentent plus de 50 % du marché mondial pour ce type d'appareil. C'est majeur, nous allons avoir accès à plus de la moitié de la tarte », note Stéphane Bédard, président et chef de la direction de B-Temia. Cette dernière compte 35 employés dans le monde, dont une vingtaine au Québec. La compagnie a également une division en Asie en partenariat avec Wistron Corporation. Le siège social est à Singapour. Déjà aux États-Unis Mentionnons que dans le cadre d'un partenariat signé en 2018 avec l'entreprise Lockheed Martin, B-Temia travaillait déjà sur certains produits destinés à l'armée américaine. « Le dossier militaire fait intervenir des personnes saines. Lorsque les gens n'ont pas de maladie, la FDA n'intervient pas. Le même produit peut être utilisé pour d'autres objectifs que de restaurer la démarche », dit M. Bédard. L'exosquelette développé pour les militaires améliore notamment leur performance lorsqu'ils doivent transporter de l'équipement sur une plus longue période et aide à prévenir les blessures, avance le président. L'appareil en question fournit une force supplémentaire aux genoux. Gr'ce à l'autorisation de la FDA, B-Temia prévoit prendre de l'expansion au cours des prochaines années, entre autres à Québec où plus de 10 millions $ devraient être injectés. Des embauches seront aussi effectuées. L'entreprise était en discussion avec la FDA depuis 2016. La direction souligne également son intention de poursuivre ses démarches pour obtenir les approbations réglementaires nécessaires dans d'autres pays. Plusieurs projets en chantier Quant à l'expansion au sud de la frontière canadienne, B-Temia, qui a été fondée en 2010, analyse différents scénarios. Comme pour l'Asie, cette offensive pourrait se faire avec l'aide d'un partenaire d'affaires. « On veut rendre accessible le plus rapidement cette technologie à travers le monde. Oui, on pourrait avoir des activités directes sur le territoire américain. Le modèle d'affaires pour les États-Unis est à l'étude », affirme M. Bédard, précisant ne pas avoir d'échéancier à fournir pour le moment. Par ailleurs, « l'armée suisse fait également des essais avec nos produits. Nous avons aussi d'autres projets militaires sur la table », conclut-il. Afin d'appuyer sa croissance, la direction de B-Temia n'écarte pas la possibilité de faire le saut à la Bourse d'ici cinq ans. Le produit développé par B-Temia, qui est aussi commercialisé au Canada, pourrait notamment servir pour améliorer la démarche des patients ayant subi un AVC. https://www.journaldequebec.com/2020/09/15/b-temia-gagne-en-force-aux-etats-unis

  • Seaspan Announces Closing of Second $500 Million Investment by Fairfax Financial Holdings Limited

    January 16, 2019 | Local, Naval

    Seaspan Announces Closing of Second $500 Million Investment by Fairfax Financial Holdings Limited

    HONG KONG, Jan. 15, 2019 /CNW/ - Seaspan Corporation (NYSE: SSW) ("Seaspan") announced today the closing of the second tranche of the $1 billion aggregate investment commitment by Fairfax Financial Holdings Limited and its affiliates (collectively, "Fairfax") in Seaspan. As with Fairfax's initial $500 million investment in Seaspan, and pursuant to definitive agreements entered into on March 13, 2018 and announced on March 14, 2018, this second tranche of funding (the "Second Fairfax Investment") is structured as a $250 million issuance of (i) 5.50% senior notes due 2026 and (ii) approximately 38.46 million warrants (the "2019 Warrants"). Pursuant to a definitive agreement entered into and announced on May 31, 2018, Fairfax has agreed to immediately exercise the 2019 Warrants at an exercise price of $6.50per warrant, for additional equity proceeds to Seaspan of $250 million. As a result, Seaspan's aggregate proceeds from the Second Fairfax Investment will be $500 million. This brings Fairfax's total investment in Seaspan to $1 billion, the proceeds of which will be used to fund future growth initiatives, repay debt and for general corporate purposes. With the closing of the Second Fairfax Investment, Fairfax's aggregate shareholdings in Seaspan are 76.9 million Class A common shares or approximately 36% of shares outstanding. Fairfax continues to hold the 25 million seven year warrants, with an exercise price of $8.05, which were issued to it on July 16, 2018. Summary of Fairfax Investments1 Investment Date Issued/Exercised Proceeds to Seaspan 2025 Notes February 14, 2018 $250 million 2018 Warrants July 16, 2018 $250 million 2026 Notes January 15, 2019 $250 million 2019 Warrants January 15, 2019 $250 million 1 Does not include the 25 million seven year warrants outstanding as of the date hereof David Sokol, Chairman of Seaspan Corporation commented, "The closing of this follow-on Fairfax investment bolsters Seaspan's balance sheet for the future. Seaspan's management team and Board of Directors are proud to continue building upon the strong partnership created with Fairfax. This additional investment will enhance Seaspan's ability to execute on our long-term goals of deleveraging, strengthening our balance sheet, and creating value through disciplined and thoughtful capital allocation." Prem Watsa, Chairman and Chief Executive Officer of Fairfax said, "With the closing of this investment, we are excited to expand our partnership with Seaspan, which now represents one of Fairfax's largest investments." About Seaspan Seaspan is a leading independent charter owner and operator of containerships with industry leading ship management services. We charter our vessels primarily pursuant to long-term, fixed-rate, time charters to the world's largest container shipping liners. Seaspan's operating fleet consists of 112 containerships with a total capacity of more than 900,000 TEU, an average age of approximately 6 years and an average remaining lease period of approximately 4 years, on a TEU-weighted basis. Seaspan has the following securities listed on The New York Stock Exchange: Symbol: Description: SSW Class A common shares SSW PR D Series D preferred shares SSW PR E Series E preferred shares SSW PR G Series G preferred shares SSW PR H Series H preferred shares SSW PR I Series I preferred shares SSWN 6.375% senior unsecured notes due 2019 SSWA 7.125% senior unsecured notes due 2027 SSW25 5.500% senior notes due 2025 About Fairfax Financial Holdings Limited Fairfax is a holding company which, through its subsidiaries, is engaged in property and casualty insurance and reinsurance and investment management. Investor Inquiries: Mr. Matt Borys Investor Relations Seaspan Corporation Tel. +1-778-328-5340 Email: mborys@seaspanltd.ca SOURCE Seaspan Corporation https://www.newswire.ca/news-releases/seaspan-announces-closing-of-second-500-million-investment-by-fairfax-financial-holdings-limited-848167000.html

  • FrontLine: Who's Where?

    October 29, 2018 | Local, Aerospace, Naval, Land, C4ISR, Security

    FrontLine: Who's Where?

    DND Ombudsman, Management & Program Consultants, L3 Technologies, Ultra Electronics, CAF/NATO. https://defence.frontline.online/article/2018/5/10562-Who%27s-Where%3F

All news